|
|
|
|
| LEADER |
02038nmm a2200517 u 4500 |
| 001 |
EB002166180 |
| 003 |
EBX01000000000000001303959 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
230607 ||| eng |
| 020 |
|
|
|a 9780841231917
|
| 050 |
|
4 |
|a RS403
|
| 100 |
1 |
|
|a Abdel-Magid, Ahmed F.
|e [editor]
|
| 245 |
0 |
0 |
|a Comprehensive Accounts of Pharmaceutical Research and Development, Volume 2
|b From Discovery to Late-Stage Process Development
|c Ahmed F. Abdel-Magid, editor, Jaan A. Pesti, editor, Rajappa Vaidyanathan, editor ; sponsored by the ACS Division of Organic Chemistry
|
| 260 |
|
|
|a Washington, DC
|b American Chemical Society
|c 2016, 2016
|
| 300 |
|
|
|a 347 pages
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references and index
|
| 653 |
|
|
|a Pharmaceutical chemistry
|
| 653 |
|
|
|a Enzyme inhibitors / Development
|
| 653 |
|
|
|a MEDICAL / Pharmacology / bisacsh
|
| 653 |
|
|
|a Drug Design
|
| 653 |
|
|
|a MEDICAL / Research / bisacsh
|
| 653 |
|
|
|a Glucocorticoids / antagonists & inhibitors
|
| 653 |
|
|
|a Drug Industry / instrumentation
|
| 653 |
|
|
|a Ubiquitins
|
| 653 |
|
|
|a Chemistry, Pharmaceutical
|
| 653 |
|
|
|a Drug Evaluation
|
| 653 |
|
|
|a Drugs / Testing
|
| 653 |
|
|
|a Drug development
|
| 653 |
|
|
|a Chemical inhibitors / Development
|
| 653 |
|
|
|a Glucocorticoids / Antogonists / Development
|
| 653 |
|
|
|a Drug antagonism / Development
|
| 653 |
|
|
|a Drugs / Design
|
| 653 |
|
|
|a Drug Antagonism
|
| 653 |
|
|
|a Drug Industry
|
| 653 |
|
|
|a Pharmaceutical industry / Technological innovations
|
| 653 |
|
|
|a Enzyme Inhibitors
|
| 700 |
1 |
|
|a Pesti, Jaan A.
|e [editor]
|
| 700 |
1 |
|
|a Vaidyanathan, Rajappa
|e [editor]
|
| 710 |
2 |
|
|a American Chemical Society
|b Division of Organic Chemistry
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b ACS
|a ACS Symposium Series
|
| 490 |
0 |
|
|a ACS symposium series
|
| 500 |
|
|
|a Distributed in print by Oxford University Press
|
| 856 |
4 |
0 |
|u https://pubs.acs.org/doi/book/10.1021/bk-2016-1240
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 615.1/9
|